Tuesday, October 25, 2011

• 23andMe Discovers Genetic Variant That May Protect Those at High Risk for Parkinson's Disease

  MOUNTAIN VIEW, Calif., Oct. 25, 2011 /PRNewswire/ -- 23andMe, Inc., a leading personal genetics company, has announced the first-time discovery of the potentially protective nature of the gene serum/glucocorticoid regulated kinase 1 (SGK1) which appears to be protective against a high-risk leucine-rich repeat kinase 2 (LRRK2) mutation for Parkinson's disease ... read more